A family-owned company with a long-standing tradition

Geistlich Pharma has been family-owned since 1851. It all began with a glue producing company in Zürich. From bone and tissue specialists to internationally renowned regeneration experts: a history in four chapters.

 

 

Expertise since 1851

Since 1851 the family-owned company has been processing raw materials in Zürich, the same materials as it makes today: bone and skin. Then glue was produced, first in Zürich and later in Schlieren in the canton of Zürich. Organic fertilizer was later added to the product list. The DNA of Geistlich Pharma’s three current business units came about from this. All three units developed from the processing of bone and tissue.

The door to the pharmaceutical industry opens

During the Second World War, Geistlich Pharma’s expertise was in high demand: from the 1940s onwards, its nutritional replacement product alleviated osteoporosis in the destitute population. This product marked the company’s entrance into the pharmaceutical industry. In the 1950s, Geistlich expanded abroad for the first time: the company established its first affiliates in the UK (Geistlich Sons Ltd.) and Germany. Further products were added to the product range, including gelatin, which was produced until 2002, and cosmetics. It stopped producing cosmetics in the 1980s. Its pharmaceutical products such as Taurolin® and the medical device TauroSept® are still produced today.

 

“Geistlich grows organically. Our fuel is our pioneering spirit.”
Paul Note, CEO Geistlich Pharma

 

Dr. Peter Geistlich – the pioneer of regenerative biomaterials

Dr. Peter Geistlich, President of the Administrative Board, laid the foundation stone of today’s company. He had a vision, which he knew how to fulfill with his passion for science: natural bone and tissue regeneration using regenerative biomaterials. He did exactly what Geistlich still does today: he cooperated with international researchers, in particular Prof. Dr. Philip Boyne from Loma Linda University in California. His pioneering work in bone regeneration led to the development of the bone substitute Geistlich Bio-Oss®. As a pioneer, he developed a market for regenerative dentistry in the 1980s, which has taken on global dimensions today. He also launched Geistlich Orthoss®, the bone substitute for use in orthopedic bone defects. In the 1990s, further pioneering products came on the market: Geistlich Bio-Gide®, a collagen membrane for use in dentistry, and Chondro-Gide®, a collagen matrix for the regeneration of cartilage defects.

 

From pioneer to leading global regeneration expert

The pioneering role of Geistlich as a creator and designer of a new business area paid off. Today, the company sets the standard for regenerative dentistry, the area in which it has been world leader for decades. It expertise is continually expanding. With scientific evidence to support it, the company continues to enter further areas such as orthopedics and medicine.

 


Dr. Mirjam Kessler
Director Corporate Communications